Clinical Trial Update: A Study of Minirin Melt in Patients With Nocturia

View source ↗

Summary

This update notes the completion of a clinical trial evaluating Minirin Melt in patients with nocturia. The sponsor for the study is Ferring Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Drugs mentioned

• Minirin Melt (desmopressin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturia | Status: COMPLETED